Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MBOT
Strong SellSinkerMicrobot Medical Inc. · Healthcare · United States · $99M · Avg Vol: $1M/d
COMPANY DESCRIPTION
Microbot Medical Inc. is a medical device company developing disposable, remote-controlled micro-robotic systems for various endovascular and minimally invasive procedures. Its patented Liberty™ Robotic System aims to enhance precision and safety, providing a differentiated offering in the growing medical robotics market. The company is a niche innovator focused on disrupting traditional catheter-based interventions with its advanced micro-robotic technology.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | — | — | 1.6M | 8.8M | — |
| EPS | -1.59 | -0.21 | -0.18 | -0.21 | -0.29 | — | -0.25 | -0.31 | -0.34 | — |
| Shares | 7.1M | 67.2M | 67.2M | 67.2M | 67.2M | +844.8% | 67.2M | — | — | — |
| Debt | 0.7M | 0.5M | 0.2M | 0.1M | 0.9M | 6.2% | 0.9M | — | — | — |
| Equity | 14.4M | 7.3M | 4.5M | 3.5M | 77.6M | 52.4% | — | — | — | — |
| Op CF | -9.4M | -11.5M | -8.5M | -8.8M | -13.0M | — | -17.6M | — | — | — |
| Inv CF | 3.2M | -3.8M | 2.0M | 1.5M | -72.4M | — | — | — | — | — |
| Fin CF | 0 | 4.3M | 6.6M | 7.9M | 86.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MBOT are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MBOT | Microbot Medical Inc.(you) | $99M | 7 | Strong Sell |
| RPID | Rapid Micro Biosystems, Inc. | $79M | 6 | Strong Sell |
| CVRX | CVRx, Inc. | $79M | 9 | Strong Sell |
| HYPR | Hyperfine, Inc. | $88M | 12 | Strong Sell |
| EBR.AX | EBR Systems, Inc. | $148M | 5 | Strong Sell |
| SERA | Sera Prognostics, Inc. | $82M | 14 | Strong Sell |
| QTRX | Quanterix Corporation | $125M | 14 | Strong Sell |
| LDX.AX | Lumos Diagnostics Holdings Limited | $68M | 3 | Strong Sell |
| QSI | Quantum-Si incorporated | $171M | 11 | Strong Sell |
| OWLT | Owlet, Inc. | $146M | 15 | Strong Sell |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.3%